Decreased amount of vimentin N-terminal truncated proteolytic products in parkin-mutant skin fibroblasts (original) (raw)

Altered protein expression pattern in skin fibroblasts from parkin -mutant early-onset Parkinson's disease patients

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015

Genes & Development

Aberrant proteins expressed in skin fibroblasts of Parkinson's disease patients carrying heterozygous variants of glucocerebrosidase and parkin genes

Kawinthra Khwanraj

Biomedical Reports

View PDFchevron_right

Vimentin Diversity in Health and Disease

Franziska Lautenschläger

Cells, 2018

View PDFchevron_right

Cytoskeletal alterations of parkin-mutant human primary fibroblasts

R. Rinaldi, Antonio Gaballo, MICHELE MAFFIA, Stefano Leporatti

Journal of Biotechnology, 2014

View PDFchevron_right

Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations

Mario Ezquerra

Aging, 2019

View PDFchevron_right

Primary Skin Fibroblasts as a Model of Parkinson's Disease

Wolfram Kunz

Molecular Neurobiology, 2012

View PDFchevron_right

Vimentin Plays a Crucial Role in Fibroblast Ageing by Regulating Biophysical Properties and Cell Migration

Kristina SLiogeryte

Cells

View PDFchevron_right

Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts

Andrew Maniotis

Journal of Cell Science, 1998

View PDFchevron_right

Senescence and cytoskeleton: overproduction of vimentin induces senescent-like morphology in human fibroblasts

Akira Inoue

Histochemistry and Cell Biology, 2001

View PDFchevron_right

Cytoskeletal Alterations and Biomechanical Properties of parkin-Mutant Human Primary Fibroblasts

Angelo Santino, Stefano Leporatti

Cell Biochemistry and Biophysics, 2014

View PDFchevron_right

Significance of the parkin gene and protein in understanding Parkinson's disease

George Oyler

Current neurology and neuroscience reports, 2002

View PDFchevron_right

Vimentin Intermediate Filaments as Potential Target for Cancer Treatment

Magdalena Přechová

Cancers, 2020

View PDFchevron_right

Vimentin Is the Specific Target in Skin Glycation

Thomas Kueper

Journal of Biological Chemistry, 2007

View PDFchevron_right

Part I: Parkin-associated proteins and Parkinson's disease

B. Sommer, Herman Van Der Putten

Neuropharmacology, 2003

View PDFchevron_right

Vimentin Is the Specific Target in Skin Glycation: STRUCTURAL PREREQUISITES, FUNCTIONAL CONSEQUENCES, AND ROLE IN SKIN AGING

Thomas Blatt

Journal of Biological Chemistry, 2007

View PDFchevron_right

Vimentin in the Central Nervous System

Paola Strocchi

Differentiation, 1982

View PDFchevron_right

In: Vimentin Concepts and Molecular Mechanisms VimentinduringDevelopment: Expression,Regulation andFunctions

Denise Paulin

View PDFchevron_right

Amino acid sequence characterization of mammalian vimentin, the mesenchymal intermediate filament protein

Klaus Weber, Uwe Plessmann

FEBS Letters, 1983

View PDFchevron_right

Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network

Steven Nordeen

The Journal of Cell Biology, 1990

View PDFchevron_right

Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells

Sophia Schedin Weiss

Molecular Neurobiology, 2014

View PDFchevron_right

Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding

Alma Martínez Fernández

Nature Communications, 2015

View PDFchevron_right

The vimentin cytoskeleton: when polymer physics meets cell biology

Bobby Carroll

Physical Biology, 2020

View PDFchevron_right

Structure and Assembly Properties of the Intermediate Filament Protein Vimentin: The Role of its Head, Rod and Tail Domains

Kenneth Goldie

Journal of Molecular Biology, 1996

View PDFchevron_right

Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches

Nil GÜZEL

Neurochemistry International, 2015

View PDFchevron_right

Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients

Ing Bgsh

Human Molecular Genetics, 2010

View PDFchevron_right

Decreased amount of vimentin N-terminal truncated proteolytic products in parkin-mutant skin fibroblasts (original) (raw)

Related papers